87 related articles for article (PubMed ID: 10891786)
1. [The financial impact of maintenance treatment in heroin addictive behavior: the case of Subutex].
Kopp P; Rumeau-Pichon C; Le Pen C
Rev Epidemiol Sante Publique; 2000 Jun; 48(3):256-70. PubMed ID: 10891786
[TBL] [Abstract][Full Text] [Related]
2. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
Fhima A; Henrion R; Lowenstein W; Charpak Y
Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
[TBL] [Abstract][Full Text] [Related]
3. [Dependence on psychotropic drugs and substitution treatment: recent trends. The OPPIDUM study of the Centers for Evaluation and Information on Drug Dependence (CEIP), October 1997].
Thirion X; Micallef J; Guet F; Delarozière JC; Arditti J; Huntsman A; Sanmarco JL; Lagier G
Therapie; 1999; 54(2):243-9. PubMed ID: 10394261
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence.
Bell J; Shanahan M; Mutch C; Rea F; Ryan A; Batey R; Dunlop A; Winstock A
Addiction; 2007 Dec; 102(12):1899-907. PubMed ID: 17784896
[TBL] [Abstract][Full Text] [Related]
5. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
Duburcq A; Charpak Y; Blin P; Madec L
Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
[TBL] [Abstract][Full Text] [Related]
6. A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal.
Doran CM; Shanahan M; Bell J; Gibson A
Drug Alcohol Rev; 2004 Jun; 23(2):171-5. PubMed ID: 15370023
[TBL] [Abstract][Full Text] [Related]
7. Role of buprenorphine in the management of heroin addiction.
Sung S; Conry JM
Ann Pharmacother; 2006 Mar; 40(3):501-5. PubMed ID: 16434562
[TBL] [Abstract][Full Text] [Related]
8. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
[TBL] [Abstract][Full Text] [Related]
9. [Questionnaire study of general practitioners regarding experience and attitude to opioid substitution therapy].
Mravcík V; Coufalová M; Popov P; Zábranský T; Procházka R
Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):27-33. PubMed ID: 15810140
[TBL] [Abstract][Full Text] [Related]
10. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting.
Harris AH; Gospodarevskaya E; Ritter AJ
Pharmacoeconomics; 2005; 23(1):77-91. PubMed ID: 15693730
[TBL] [Abstract][Full Text] [Related]
11. Economic and social effects of high-dose buprenorphine substitution therapy. Six-month results.
Lavignasse P; Lowenstein W; Batel P; Constant MV; Jourdain JJ; Kopp P; Reynaud-Maurupt C; Riff B; Videau B; Mucchielli A
Ann Med Interne (Paris); 2002 May; 153(3 Suppl):1S20-6. PubMed ID: 12218879
[TBL] [Abstract][Full Text] [Related]
12. Value for money in drug treatment: economic evaluation of prison methadone.
Warren E; Viney R; Shearer J; Shanahan M; Wodak A; Dolan K
Drug Alcohol Depend; 2006 Sep; 84(2):160-6. PubMed ID: 16487668
[TBL] [Abstract][Full Text] [Related]
13. A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
Shanahan MD; Doran CM; Digiusto E; Bell J; Lintzeris N; White J; Ali R; Saunders JB; Mattick RP; Gilmour S
Addict Behav; 2006 Mar; 31(3):371-87. PubMed ID: 15972245
[TBL] [Abstract][Full Text] [Related]
14. Bupreorphine:a new pharmacotherapy for opioid addictions treatment.
Stock C; Shum JH
J Pain Palliat Care Pharmacother; 2004; 18(3):35-54. PubMed ID: 15364630
[TBL] [Abstract][Full Text] [Related]
15. Infective endocarditis secondary to intravenous Subutex abuse.
Chong E; Poh KK; Shen L; Yeh IB; Chai P
Singapore Med J; 2009 Jan; 50(1):34-42. PubMed ID: 19224082
[TBL] [Abstract][Full Text] [Related]
16. Comparison of costs and utilization among buprenorphine and methadone patients.
Barnett PG
Addiction; 2009 Jun; 104(6):982-92. PubMed ID: 19466922
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of methadone maintenance.
Barnett PG; Hui SS
Mt Sinai J Med; 2000; 67(5-6):365-74. PubMed ID: 11064486
[TBL] [Abstract][Full Text] [Related]
18. The costs and consequences of three policy options for reducing heroin dependency.
Moore TJ; Ritter A; Caulkins JP
Drug Alcohol Rev; 2007 Jul; 26(4):369-78. PubMed ID: 17564872
[TBL] [Abstract][Full Text] [Related]
19. Managing opioid addiction with buprenorphine.
Donaher PA; Welsh C
Am Fam Physician; 2006 May; 73(9):1573-8. PubMed ID: 16719249
[TBL] [Abstract][Full Text] [Related]
20. Quality of life among heroin users on buprenorphine versus methadone maintenance.
Ponizovsky AM; Grinshpoon A
Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
